Assessment of Pre-Referral Treatment of Severe Malaria Among Children Seen at a Referral Health Facility in South-Western Nigeriaa.
Article Sidebar
Main Article Content
Abstract
Background
In settings where intravenous artesunate and supportive care cannot be guaranteed, timely and efficient administration of pre-referral antimalarial is crucial. The study aimed to determine the prevalence of pre-referral treatment of severe malaria, the type of pre-referral antimalarial given, and the relationships between pre-referral treatment and outcomes of childhood severe malaria at a referral health facility.
Methods
This is a retrospective cross-sectional study that involved the review of clinical admission of children aged one month to 15 years referred from a health facility due to suspected severe malaria and who had parasitological evidence of plasmodium falciparum. Diagnosis of severe malaria was made based on clinical features consistent with the World Health Organisation (WHO) criteria.
Results
109 medical records were reviewed. The children had a median (IQR) age of 2.0 (4.25) years. The subjects were predominantly male: 59 (54.1%). Forty-six (42.2%) received pre-referral antimalarial; intramuscular artemether was the most common pre-referral antimalarial drug recorded in 33 (30.3%) of the participants. None received rectal artesunate as a pre-referral antimalaria drug. Severe anaemia, prostration, and cerebral malaria were the most frequent components of severe malaria occurring in 26 (23.9%), 24 (22.0%), and 23 (21.1%) participants, respectively. Six (5.5%) of the participants died and all of them did not receive pre-referral antimalarial treatment There was a statistically significant relationship between pre-referral antimalarial treatment and disease outcome (p = 0.024), as none of the children who died from severe malaria received pre-referral treatment.
Conclusions:
The proportion of children with severe malaria who received pre-referral antimalarial was 42.2%. Intramuscular artemether was the most common pre-referral antimalarial given. Pre-referral antimalaria treatment reduces mortality associated with severe malaria in children.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
How to Cite
References
Snow RW. Global malaria eradication and the importance of Plasmodium falciparum epidemiology in Africa. BMC Med. 2015; 13:23. doi: 10.1186/s12916-014-0254-7. DOI: https://doi.org/10.1186/s12916-014-0254-7
Olliaro P. Mortality Associated with Severe Plasmodium falciparum Malaria Increases with Age. Clin Infect Dis. 2008;47(2):158–160. DOI: https://doi.org/10.1086/589288
WHO. World Malaria Report 2023. Geneva: World Health Organization; 2023. Available from: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023 [Accessed 24th June, 2024]
Odeyemi AO, Olasinde YT, Ojewuyi AR, Odeyemi AO, Ala OA, Agelebe E. Utilization of long-lasting insecticidal net among children aged less than five years in a tertiary health facility in south-west Nigeria. Alex. J. Med.2020;58(1):44-51 DOI: https://doi.org/10.1080/20905068.2022.2067678
Odeyemi AO, Olasinde YT, Ojewuyi AR, Odeyemi AO, Ala OA. Malaria parasitaemia and its associated factors among febrile children in a tertiary hospital in Southwest Nigeria. West Afr J Med 2022;39(3):214-319.
WHO guidelines for malaria, 2023. Geneva: World Health Organization. Available at: https://iris.who.int/bitstream/handle/10665/373339/WHO-UCN-GMP-2023.01-Rev.1 [Accessed 20th June, 2024].
Hetzel MW, Okitawutshu J, Tshefu A, Omoluabi E, Awor P, Signorell A, et al. Effectiveness of rectal artesunate as pre-referral treatment for severe malaria in children under 5 years of age: a multi-country observational study. BMC Med. 2022;20(1):343. doi: 10.1186/s12916-022-02541-8. DOI: https://doi.org/10.1186/s12916-022-02541-8
Edelu BO, Ndu IK, Igbokwe O, Iloh ON. Severe falciparum malaria in children in Enugu, South East Nigeria. Niger J Clin Pract. 2018; 21:1349–55. DOI: https://doi.org/10.4103/njcp.njcp_140_18
Mockenhaupt FP, Ehrhardt S, Burkhardt J, Bosomtwe SY, Laryea S, Anemana SD et al. Manifestation and outcome of severe malaria in children in Northern Ghana. Am J Trop Med Hyg 2004; 71:167‑72 DOI: https://doi.org/10.4269/ajtmh.2004.71.167
WHO. Pre-referral treatment with rectal artesunate of children with suspected severe malaria: a field guide. Geneva: World Health Organization; 2023. Available at https://iris.who.int/bitstream/handle/10665/373915/9789240082953-eng.pdf?sequence=1 [Accessed 20th June, 2024].
Orimadegun AE, Fawole O, Okereke JO, Akinbami FO, Sodeinde O. Increasing burden of childhood severe malaria in a Nigerian tertiary hospital: implication for control. J. Trop. Pediatr.2007;53(3):185–89. DOI: https://doi.org/10.1093/tropej/fmm002
Hien TT, Davis TM, Chuong LV, Ilett KF, Sin h DXT, Phu NH et al. Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrob Agents Chemother. 2004;48(11):4234-39. DOI: https://doi.org/10.1128/AAC.48.11.4234-4239.2004
Esu EB, Effa EE, Opie ON, Meremikwu MM. Artemether for severe malaria. Cochrane Database Syst Rev. 2019;6(6):CD010678. DOI: https://doi.org/10.1002/14651858.CD010678.pub3
Dondorp AM, Fanello CI, Hendricksen ICE, Gomes E, Seni A, Chhaganlal KD et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2.010; 376(9753):1647-57
Awor P, Kimera J, Athieno P, Tumukunde G, Okitawutshu J, Tshefu A et al. Acceptability of pre-referral rectal artesunate for severe malaria in children under 5 years by health workers and caregivers in the Democratic Republic of the Congo, Nigeria and Uganda. Malar J. 2022;21(1):322. doi: 10.1186/s12936-022-04348-7 DOI: https://doi.org/10.1186/s12936-022-04348-7
Federal Ministry of Health (FMoH). National Guidelines for Diagnosis and Treatment of Malaria. 4th ed. Abuja, Nigeria: NMEP; 2020. 0. https://drive.google.com/file/d/1pxGgYsCjEWYDQ5-2GM5PSeeWHXww7erK/view. [Accessed: 14th June, 2024].
Gomes MF, Faiz MA, Gyapong JO, Warsame M, Agbenyega T, Babiker A et al. Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet. 2009; 373: 557-566 DOI: https://doi.org/10.1016/S0140-6736(08)61734-1
White NJ. Anaemia and malaria. Malar J 2018;17,371. https://doi.org/10.1186/s12936-018-2509-9 DOI: https://doi.org/10.1186/s12936-018-2509-9
Ilunga-Ilunga F, Levêque A, Ngongo LO, Laokri S, Dramaix M. Treatment-seeking Paths in the Management of Severe Malaria in Children under 15 Years of Age Treated in Reference Hospitals of Kinshasa, Democratic Republic of Congo. Trop Med Health. 2015;43(1):11-9. DOI: https://doi.org/10.2149/tmh.2014-19
Artemisinins in Malaria Therapy, 1st; Li, Q.; Milhous, W.K.; Weina, P. (Eds.) Nova Science Publishers Inc: New York, NY, USA, 2007; P 1–33.